This week's FierceLifeSci is brought to you by the FierceBiotech Drug Development Forum.
|
| Register today to hear from 70+ biotech industry leading speakers. | | | | BROCHURE | FACULTY | REGISTER | | Biopharma companies need to adopt creative deal-making and partnership strategies in order to secure financing during this period of high regulatory scrutiny and shaky IPO markets. The FierceBiotech 2nd Drug Development Forum (September 25–27 in Boston) goes into unprecedented depth on how you can pitch the best partnerships for drug development and licensing while navigating financial and regulatory changes. Don't miss our full two-day track devoted entirely to strategic deal-making! DOWNLOAD THE BROCHURE HERE | Anticipate the Responses and Judgments of Venture Capitalists to a Crowded Market | | | Luba Greenwood,
Vice President, Global Mergers, Acquisitions and Business Development, ROCHE |
| | | Eva Jack,
CBO, MERSANA THERAPEUTICS |
| | | Brian Gallagher,
Partner, SR ONE |
| | | Rosemary Reilly,
Partner, WILMERHALE |
|
| Enable Flexibility, Creativity, and Independence in Partnerships Between Large and Small Biotech Companies | | | Michael Bailey,
CEO, AVEO ONCOLOGY |
| | | Cynthia Schwalm,
President, North American Commercial Operations, IPSEN |
| | | Rich Murray,
CEO, JOUNCE THERAPEUTICS |
| | | Chandra Ramanathan,
Vice President and Head, East Coast Innovation Center, BAYER |
|
| Evaluate the Risks and Benefits of Deal Complexity: What Really Generates Value? | | | | Angus Grant, Corporate Vice President, Business Development, CELGENE |
| | | | Bruce Goldsmith, COO, LYCERA |
|
| Secure Funding for Preclinical Companies | | | | David Sherris, CEO, GENADAM THERAPEUTICS |
| | | | Maria Vilenchik, CEO, FELICITEX THERAPEUTICS |
| | | | Nikola Trbovic, Senior Director, Head of R&D Technology Strategy, Worldwide R&D, PFIZER |
| | | | Carl Berke, Partner, PARTNERS HEALTHCARE VENTURES |
|
| | | | Kevin Bitterman, Partner, ATLAS VENTURES |
| | | | Dennis Ford, CEO, LIFE SCIENCE NATION |
| | | | Richard Anders, Founder, MASS MEDICAL ANGELS |
|
| Pioneer Novel Deal Structures in a Changing Marketplace | | | | Shakti Narayan, Vice President, Head of Transactions, JOHNSON & JOHNSON |
| | | | Casey Logan, CBO, TRACON PHARMACEUTICALS |
|
| | Register today and do not miss out on this one-of-a-kind learning and networking experience! Be sure to use Priority Code C942EM9. I look forward to seeing you in Boston this fall! Sincerely, Matt Greenbaum
Production Team Leader
ExL Events, a division of Questex, LLC | | SPONSORED BY: | | | | For information on exhibition and sponsorship opportunities, please contact Andrew Sinetar at 212-400-6237 or asinetar@exlevents.com. | Forward this email to a colleague
Copyright © 2017 ExL Events, All rights reserved.
494 8th Avenue, 4th Floor, New York, NY 10001
Phone: 212-400-6240
Email: info@exlevents.com
|
|
Reach 300,000+ subscribers with your own message.
Contact Angelique Alcover at aalcover@fiercemarkets.com or call 202-824-5074.
About this email: In order to receive FierceLifeSci for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceLifeSci . [Click here] to unsubscribe.
FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036 |
|
